Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Lecompte

Showing results (141-150 of 166) with videos related to

Pageof 17
Sort By:
Haematologica|June 2, 2016
Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemiaAgnès Charpentier, Aurélien Lebreton, Antoine Rauch, et al.
Thrombosis Research|May 24, 2021
Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccinationJonathan Douxfils, Julien Favresse, Jean-Michel Dogné, et al.
Archives of Cardiovascular Diseases|January 10, 2019
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR)Anne Godier, Dephine Garrigue, Dominique Lasne, et al.
Transfusion|May 13, 2017
Metagenomics analysis of red blood cell and fresh-frozen plasma unitsPierre Lau, Samuel Cordey, Francisco Brito, et al.
Thrombosis Research|November 8, 2020
Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational studyMichaël Hardy, Isabelle Michaux, Sarah Lessire, et al.
Data in Brief|November 17, 2020
Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily dataMichaël Hardy, Isabelle Michaux, Sarah Lessire, et al.
Critical Care Medicine|December 30, 2008
Activated protein C improves lipopolysaccharide-induced cardiovascular dysfunction by decreasing tissular inflammation and oxidative stressNacira Sennoun, Sennoun Nacira, Ferhat Meziani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 5, 2011
Tissue factor pathway inhibitor: a new link among arterial stiffness, pulse pressure, and coagulation in postmenopausal womenVeronique Regnault, Christine Perret-Guillaume, Anna Kearney-Schwartz, et al.
Research and Practice in Thrombosis and Haemostasis|August 18, 2025
Fibrinography and thrombography (thrombodynamics-4D) in atrial fibrillation assessment of direct oral anticoagulants in geriatrics patients aged 80 years and older receiving direct oral anticoagulant therapyGeoffrey Foulon-Pinto, Georges Jourdi, Maxime Delrue, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2019
Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variabilityVirginie Siguret, Johan Abdoul, Xavier Delavenne, et al.
Pageof 17

Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Haematologica|June 2, 2016
Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemiaAgnès Charpentier, Aurélien Lebreton, Antoine Rauch, et al.
Thrombosis Research|May 24, 2021
Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccinationJonathan Douxfils, Julien Favresse, Jean-Michel Dogné, et al.
Archives of Cardiovascular Diseases|January 10, 2019
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR)Anne Godier, Dephine Garrigue, Dominique Lasne, et al.
Transfusion|May 13, 2017
Metagenomics analysis of red blood cell and fresh-frozen plasma unitsPierre Lau, Samuel Cordey, Francisco Brito, et al.
Thrombosis Research|November 8, 2020
Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational studyMichaël Hardy, Isabelle Michaux, Sarah Lessire, et al.
Data in Brief|November 17, 2020
Prothrombotic hemostasis disturbances in patients with severe COVID-19: Individual daily dataMichaël Hardy, Isabelle Michaux, Sarah Lessire, et al.
Critical Care Medicine|December 30, 2008
Activated protein C improves lipopolysaccharide-induced cardiovascular dysfunction by decreasing tissular inflammation and oxidative stressNacira Sennoun, Sennoun Nacira, Ferhat Meziani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 5, 2011
Tissue factor pathway inhibitor: a new link among arterial stiffness, pulse pressure, and coagulation in postmenopausal womenVeronique Regnault, Christine Perret-Guillaume, Anna Kearney-Schwartz, et al.
Research and Practice in Thrombosis and Haemostasis|August 18, 2025
Fibrinography and thrombography (thrombodynamics-4D) in atrial fibrillation assessment of direct oral anticoagulants in geriatrics patients aged 80 years and older receiving direct oral anticoagulant therapyGeoffrey Foulon-Pinto, Georges Jourdi, Maxime Delrue, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2019
Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variabilityVirginie Siguret, Johan Abdoul, Xavier Delavenne, et al.
Pageof 17